Back to results
US 2012/0251563 A1Published application
Modulation of immune response by non-peptide binding stress response polypeptides
AssigneeDuke University
InventorsChristopher V. Nicchitta, Julie C. Baker-LePain
Life of this patent
Estimating the term…
Abstract
A recombinant stress response polypeptide that lacks an antigen binding domain, and methods for using the recombinant stress response polypeptide to elicit an immune response, for example an anti-tumor response, in a subject.
Claims8
A composition comprising:
- (a) an immunostimulatory amount of an isolated polypeptide comprising one or more modifications of a naturally occurring Grp94 polypeptide that comprises SEQ ID NO:
- 6, wherein:
- (i) relative to the naturally occurring Grp94 polypeptide, the isolated polypeptide comprises SEQ ID NO:
- 2 but lacks amino acids 601-669 and 801-804 of SEQ ID NO:
- 6;
- and
- (ii) the isolated polypeptide elicits maturation of immature dendritic cells when the immature dendritic cells are cultured in the presence of the isolated polypeptide;
- and
- (b) a pharmaceutically acceptable carrier.
6 more elements
Dependencies are inferred from the claim text.